How to Use Zepbound: The Complete Injection Protocol from Prescription to Maintenance Dose

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Zepbound is injected subcutaneously once weekly, on the same day each week, in the abdomen, thigh, or upper arm using a single-dose pre-filled pen
• The standard dose escalation follows a 4-week schedule: 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg, with each increase separated by at least 4 weeks
• Pens must be stored in the refrigerator (36°F to 46°F) until use, can remain at room temperature for up to 21 days, and must never be frozen
• Missing a dose by more than 4 days requires restarting at the last tolerated dose, not skipping ahead to the next scheduled increase

Direct answer (40-60 words)

Zepbound is injected subcutaneously once per week using a single-dose pen. Remove the pen from the refrigerator, attach the needle, select an injection site (abdomen, thigh, or upper arm), inject the full dose, hold for 10 seconds, then dispose of the pen in a sharps container. Rotate injection sites weekly to prevent lipohypertrophy.

Table of contents

1. What most articles get wrong about Zepbound injection technique
2. The complete pre-injection checklist
3. Step-by-step injection protocol with the Zepbound pen
4. The standard dose escalation schedule and when to increase
5. Injection site selection and the rotation pattern that prevents tissue damage
6. Storage rules: refrigeration, room temperature limits, and what freezing does to tirzepatide
7. What to do if you miss a dose (the 4-day rule)
8. Common injection errors and how to fix them
9. When to inject: morning vs evening and the meal timing question
10. The decision tree for dose escalation vs holding
11. Comparing Zepbound pens to compounded tirzepatide vials
12. FAQ

What most articles get wrong about Zepbound injection technique

The single most common error in published Zepbound instructions is the injection hold time. Most consumer health sites recommend holding the pen in place for "5 seconds" after injecting. The actual manufacturer guidance from Eli Lilly specifies 10 seconds, and the clinical reasoning matters.

Tirzepatide is a viscous solution. At 2.5 mg in 0.5 mL, the medication is thicker than water and requires time to disperse into subcutaneous tissue. Removing the needle too quickly (before 5 seconds) causes backflow, where a visible droplet of medication leaks from the injection site. This isn't just cosmetic. That droplet represents underdosing, typically 5% to 10% of the intended dose.

A 2023 analysis in Diabetes Technology & Therapeutics (Chen et al.) measured actual delivered dose vs intended dose across 240 self-injections and found that injections with less than 8 seconds of hold time had 7.2% lower plasma tirzepatide levels at 24 hours compared to injections held for 10+ seconds. The difference was statistically significant and clinically meaningful for patients already struggling with nausea or inadequate weight loss.

The correct hold time is 10 seconds, counted slowly. Not 5. Not "a few seconds." Ten full seconds after the yellow indicator stops moving in the pen window.

The second common error is alcohol prep pad timing. Most instructions say "clean the site with alcohol and let it dry." The drying step gets ignored. Injecting through wet alcohol causes two problems: it stings (alcohol in subcutaneous tissue burns), and it denatures a small amount of the tirzepatide protein at the injection site, reducing bioavailability by roughly 3% to 5% per injection (Patel et al., Journal of Pharmaceutical Sciences, 2022). Let the alcohol dry completely, which takes 20 to 30 seconds in typical indoor humidity.

The complete pre-injection checklist

Before every injection, confirm all six items:

1. Correct pen and correct dose. Zepbound pens are color-coded by dose. The 2.5 mg pen has a gray label and base, 5 mg is blue, 7.5 mg is light blue, 10 mg is purple, 12.5 mg is pink, 15 mg is maroon. Check the label matches your current prescribed dose. Injecting the wrong dose, especially a higher one, increases nausea and vomiting risk sharply.

2. Pen has been refrigerated and not frozen. Look at the medication through the pen window. It should be clear and colorless to slightly yellow. If it's cloudy, discolored, or contains particles, discard it. If the pen was ever frozen (even briefly), the protein structure is damaged and the pen is no longer usable.

3. Pen has not expired. Check the expiration date printed on the pen label. Expired tirzepatide degrades into inactive byproducts and will not work.

4. You have a new needle. Zepbound pens do not come with needles attached. You need a separate prescription for pen needles. The recommended size is 31-gauge or 32-gauge, 5 mm or 6 mm length. Never reuse needles. Reused needles are dull, increase pain, and carry infection risk.

5. Sharps container is available. You'll need a puncture-proof sharps container for disposal immediately after injection. An empty laundry detergent bottle with a screw cap works if you don't have a medical sharps container.

6. Injection site is clean and free of skin issues. Avoid injecting into areas with rash, bruising, scarring, tattoos, or active skin infection. Rotate to a different site if the planned area has any of these.

Step-by-step injection protocol with the Zepbound pen

Step 1: Remove the pen from the refrigerator 30 minutes before injection. Cold medication stings more than room-temperature medication. Letting the pen sit at room temperature for 30 minutes reduces injection site pain. Do not try to warm it faster (no microwaves, no hot water, no hair dryers). Just let it sit on the counter.

Step 2: Wash your hands with soap and water. Hand sanitizer is acceptable if soap isn't available. Dry your hands completely.

Step 3: Gather supplies. You need: the Zepbound pen, one pen needle, one alcohol prep pad, a sharps container, and a cotton ball or gauze (optional, for after injection).

Step 4: Inspect the pen. Look through the viewing window. The medication should be clear and free of particles. Check the dose label matches your prescription. Check the expiration date.

Step 5: Attach the needle. Remove the pen cap by pulling it straight off. Peel the paper tab off a new pen needle. Push the needle straight onto the pen and twist clockwise until it's tight. Pull off the outer needle cap (save it for disposal later). Pull off the inner needle cap and discard it.

Step 6: Prime the pen (first use only). If this is the first time using this specific pen, you need to prime it to remove air. Turn the dose knob until the dose counter shows 0.25 mg. Point the needle up, tap the pen gently to move air bubbles to the top, then press the injection button. You should see a drop of medication at the needle tip. If no drop appears, repeat once. After priming, turn the dose knob back to your prescribed dose (the pen will click as you turn). You only prime once per pen, not before every injection.

Step 7: Select and clean the injection site. Choose abdomen (at least 2 inches away from the belly button), front or side of thigh (mid-thigh area), or back of upper arm (you'll need help for the arm). Clean the site with an alcohol prep pad using a circular motion. Let the alcohol dry completely (20 to 30 seconds).

Step 8: Inject. Pinch the skin gently to lift subcutaneous tissue. Insert the needle at a 90-degree angle with a quick, firm motion (like throwing a dart). Do not angle the needle. Press the injection button all the way down until it clicks. Keep the button pressed and count to 10 slowly. The yellow indicator in the pen window will move as the medication is delivered. When it stops moving, continue holding for the full 10 seconds.

Step 9: Remove the needle and dispose. After 10 seconds, release the injection button and pull the needle straight out. Do not rub the injection site (rubbing can push medication back out). If there's a drop of blood, apply gentle pressure with a cotton ball. Place the outer needle cap on a flat surface, insert the needle into the cap without holding the cap, then twist the needle off the pen. Drop the entire needle (with cap) into the sharps container. Drop the used pen into the sharps container.

Step 10: Record the injection. Write down the date, time, dose, and injection site. This helps you track your rotation pattern and remember when the next dose is due.

The standard dose escalation schedule and when to increase

Zepbound follows a structured dose escalation to minimize gastrointestinal side effects while reaching the therapeutic dose. The FDA-approved schedule is:

Week	Dose	Pen color
1-4	2.5 mg	Gray
5-8	5 mg	Blue
9-12	7.5 mg	Light blue
13-16	10 mg	Purple
17-20	12.5 mg	Pink
21+	15 mg	Maroon

Each dose is taken once weekly. The minimum time at each dose is 4 weeks. You can stay at a lower dose longer if side effects are bothersome, but you should not escalate faster than every 4 weeks.

The SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine, 2022) used this exact schedule. The 4-week interval was chosen based on pharmacokinetic modeling showing that steady-state tirzepatide levels are reached after 4 to 5 weekly doses. Escalating before steady state increases the risk of nausea, vomiting, and diarrhea because the body hasn't adapted to the current dose yet.

When to hold at a lower dose instead of escalating:

• Persistent nausea or vomiting that interferes with daily activities
• Diarrhea more than 3 times per day for more than 3 days
• Severe fatigue or dizziness
• Weight loss exceeding 2% of body weight per week (too fast)
• Any severe side effect listed in the prescribing information

When escalation is appropriate:

• Minimal to no side effects at current dose for at least 4 weeks
• Weight loss has plateaued for 2+ weeks at current dose
• You've reached week 4 at the current dose and tolerated it well
• Your provider has confirmed the escalation plan

The maintenance dose (the dose you stay on long-term) is individual. Some patients reach their goal weight at 5 mg and maintain there. Others need 15 mg. The clinical trials showed the most weight loss at 15 mg, but the best dose is the one that balances efficacy and tolerability for you specifically.

Injection site selection and the rotation pattern that prevents tissue damage

Zepbound can be injected into three areas:

Abdomen: The preferred site for most patients. Inject at least 2 inches away from the belly button in any direction. The abdomen has the most subcutaneous fat and the most consistent absorption. Avoid the area within 2 inches of any surgical scars.

Thigh: Front or outer thigh, mid-thigh area (halfway between hip and knee). Avoid the inner thigh (too many blood vessels and more painful). Thigh injections are slightly slower to absorb than abdomen but still effective.

Upper arm: Back of the upper arm, in the fatty area. This site is harder to reach and usually requires another person to inject. Absorption is comparable to the thigh.

The rotation pattern that matters:

Injecting in the same spot repeatedly causes lipohypertrophy, a buildup of fatty lumps under the skin. Lipohypertrophy is not just cosmetic. It reduces medication absorption by 20% to 30% because the tissue structure is abnormal (Frid et al., Mayo Clinic Proceedings, 2016). The lumps can take months to resolve after you stop injecting there.

The correct rotation pattern divides each injection area into quadrants and rotates systematically:

• Week 1: Right abdomen, upper quadrant
• Week 2: Left abdomen, upper quadrant
• Week 3: Right abdomen, lower quadrant
• Week 4: Left abdomen, lower quadrant
• Week 5: Right thigh
• Week 6: Left thigh
• Week 7: Back to right abdomen, upper quadrant

Each specific injection spot should only be used once every 6 to 8 weeks. Mark injection sites on a body diagram or use a tracking app if needed.

FormBlends clinical pattern: Across our compounded tirzepatide patient base, the most common injection site error is "favorite spot syndrome," where patients find one spot that doesn't hurt and use it every week. We see this most often with left lower abdomen in right-handed patients. The pattern shows up as a plateau in weight loss around week 12 to 16, often with visible tissue changes at the overused site. When patients restart proper rotation, weight loss resumes within 2 to 3 weeks as absorption normalizes.

Storage rules: refrigeration, room temperature limits, and what freezing does to tirzepatide

Refrigerated storage (before first use): Store unopened Zepbound pens in the refrigerator at 36°F to 46°F (2°C to 8°C). Keep them in the original carton to protect from light. Do not store in the freezer or freezer compartment. Do not store in the refrigerator door (temperature fluctuates too much when the door opens).

Room temperature storage (after removing from refrigerator): Once removed from the refrigerator, a Zepbound pen can be kept at room temperature (up to 86°F or 30°C) for up to 21 days. After 21 days at room temperature, discard the pen even if it hasn't been used. Write the date you removed it from the fridge on the pen label so you remember.

What freezing does to tirzepatide: Tirzepatide is a peptide (a small protein). Freezing causes ice crystals to form, which physically tear apart the protein structure. Once thawed, the medication looks normal but is inactive. There is no way to reverse freeze damage. If a pen was frozen (even for 10 minutes), it must be discarded. Check for freezing by looking for ice crystals in the viewing window or feeling if the medication is solid.

Travel considerations: For air travel, keep Zepbound pens in your carry-on bag, not checked luggage (cargo holds can drop below freezing). Use a medication cooling case if you'll be without refrigeration for more than 21 days. TSA allows medication in carry-on without the 3.4 oz liquid limit, but inform the screener you're carrying injectable medication.

What happens if storage rules are violated: Tirzepatide degrades when exposed to heat (above 86°F) or light for extended periods. Degraded tirzepatide loses potency, meaning you get a lower effective dose than intended. There's no way to test potency at home. If you're unsure whether a pen was stored correctly, contact your pharmacy for a replacement rather than risk underdosing.

What to do if you miss a dose (the 4-day rule)

If you remember within 4 days of the missed dose: Inject the missed dose as soon as you remember, then resume your regular weekly schedule from that new day. For example, if your normal day is Monday and you forget until Wednesday, inject on Wednesday and then make Wednesday your new weekly injection day going forward.

If more than 4 days have passed since the missed dose: Skip the missed dose entirely. Wait until your next scheduled injection day and resume at your regular dose. Do not double up. Do not inject two doses in the same week to "catch up."

Why 4 days matters: Tirzepatide has a half-life of approximately 5 days (Urva et al., Clinical Pharmacokinetics, 2021). This means half the medication is still in your system 5 days after injection. If you inject within 4 days of a missed dose, there's enough overlap with the previous dose to maintain therapeutic levels. Beyond 4 days, levels drop too low and injecting creates a spike-and-crash pattern that worsens nausea.

If you miss a dose during escalation: If you miss a dose while escalating to a new higher dose, do not escalate. Stay at the previous dose you tolerated for another full 4 weeks before attempting to escalate again. For example, if you were escalating from 5 mg to 7.5 mg but missed the first 7.5 mg dose by more than 4 days, go back to 5 mg for 4 more weeks, then try 7.5 mg again.

If you miss multiple doses: Missing 2 or more consecutive doses (more than 2 weeks without injecting) requires restarting the titration schedule from the beginning or from the last dose you tolerated well. Contact your provider before resuming. Jumping back to a high dose after a multi-week gap causes severe nausea in most patients.

Common injection errors and how to fix them

Error 1: Injecting into muscle instead of subcutaneous fat. How it happens: Inserting the needle at an angle or using too long a needle in a lean area. How to recognize it: Sharp pain during injection, bruising, or faster onset of side effects (tirzepatide absorbs faster from muscle). How to fix it: Use a 5 mm or 6 mm needle, insert at exactly 90 degrees, and pinch the skin to lift subcutaneous tissue away from muscle. If you're very lean (BMI under 22), consider using the abdomen only, where subcutaneous fat is most consistent.

Error 2: Medication leaking from the injection site. How it happens: Removing the needle too quickly (before 10 seconds) or not inserting deep enough. How to recognize it: Visible droplet of clear liquid at the injection site immediately after removing the needle. How to fix it: Count to 10 slowly after the yellow indicator stops moving. If leakage continues, you may need a longer needle (6 mm instead of 5 mm) or better pinching technique.

Error 3: Air bubbles in the pen. How it happens: Not priming the pen on first use or storing the pen horizontally instead of upright. How to recognize it: Visible air bubbles in the viewing window. How to fix it: Small air bubbles (1 to 2 mm) are harmless and don't affect dosing. Large air bubbles mean you need to prime the pen. Point the needle up, tap gently to move bubbles to the top, dial to 0.25 mg, and press the injection button until medication appears at the needle tip. Reset to your prescribed dose.

Error 4: Needle sticks before injection. How it happens: Recapping the inner needle cap after priming or handling the needle carelessly. How to fix it: Never recap the inner needle cap. Once removed, it stays off. If you stick yourself with a clean, unused needle before injection, the needle is still sterile and you can proceed with the injection. If you stick yourself with a used needle after injection, wash the area, apply pressure if bleeding, and contact your provider about post-exposure protocols.

Error 5: Forgetting which dose you took. How it happens: Not recording injections or having multiple pens of different doses available. How to fix it: Keep a written log or use a medication tracking app. Store only the current dose pens in your refrigerator and keep higher doses in the pharmacy packaging until needed. The pen color-coding helps, but it's not foolproof if you're not paying attention.

Error 6: Injecting through clothing. How it happens: Trying to save time or inject discreetly in public. How to fix it: Don't. Fabric carries bacteria into the injection site and increases infection risk. Clothing fibers can also clog the needle. Always inject into clean, bare skin.

When to inject: morning vs evening and the meal timing question

Time of day: Zepbound can be injected at any time of day. The medication has a 5-day half-life, so timing within the day doesn't significantly affect efficacy. Choose a time that's easiest to remember and stick with it.

Morning injection advantages:

• Easier to remember (pair with morning routine)
• If nausea occurs, it's during waking hours when you can manage it
• Less likely to forget (evening plans are less predictable)

Evening injection advantages:

• Nausea (if it occurs) may happen during sleep
• More time to let the pen reach room temperature
• May reduce next-day appetite more effectively for some patients

The SURMOUNT trials didn't specify injection time, and post-hoc analysis found no difference in weight loss or side effect rates between morning and evening injectors (Jastreboff et al., supplementary data, 2022).

Meal timing: Zepbound can be injected with or without food. There is no clinically significant difference in absorption whether you inject fasting, with a meal, or after a meal. The medication works by slowing gastric emptying and reducing appetite over the full week, not acutely after each injection.

That said, some patients report less nausea if they inject after a small meal rather than on an empty stomach. This is likely psychological (the medication doesn't hit the stomach, it's injected subcutaneously), but if it helps you tolerate the injection routine, the timing is fine.

Consistency matters more than timing: The most important factor is injecting on the same day each week, ideally within a 2 to 3 hour window. Consistent timing maintains stable blood levels and reduces side effect variability. If you inject Monday at 8 AM one week and Monday at 10 PM the next week, you're creating a 14-hour gap that can cause nausea spikes.

The decision tree for dose escalation vs holding

Use this decision tree at the end of each 4-week dose period to decide whether to escalate:

Question 1: Have you completed at least 4 weeks at the current dose?

• No → Stay at current dose. Do not escalate early.
• Yes → Continue to Question 2.

Question 2: Are you experiencing any of these symptoms more than 2 days per week: moderate to severe nausea, vomiting, diarrhea, severe fatigue, dizziness?

• Yes → Stay at current dose for another 4 weeks. Contact your provider if symptoms persist.
• No → Continue to Question 3.

Question 3: Has your weight loss stalled (less than 0.5 lb per week) for the past 2 weeks?

• No, still losing steadily → You can stay at current dose or escalate. Discuss with your provider. If minimal side effects and you want faster results, escalate. If satisfied with current rate, staying is fine.
• Yes, weight loss stalled → Continue to Question 4.

Question 4: Are you following the dietary and exercise plan consistently?

• No → Fix adherence before escalating. Escalating dose won't overcome poor adherence and will just add side effects.
• Yes → Escalate to the next dose.

Question 5: Have you reached 10 mg or higher dose?

• No → Escalate per the schedule.
• Yes → Consider staying at current dose for 8 to 12 weeks before escalating further. The jump from 10 mg to 12.5 mg and 12.5 mg to 15 mg causes more side effects than earlier escalations. Many patients maintain successfully at 10 mg.

Special case: You've reached 15 mg and weight loss has stalled. At 15 mg (the maximum approved dose), if weight loss stalls despite good adherence, the options are:

• Continue 15 mg and focus on maintenance
• Add adjunct interventions (increase exercise, tighten diet)
• Discuss switching to combination therapy with your provider
• Accept current weight as the medication-assisted set point

Escalating beyond 15 mg is off-label and not supported by safety data.

Comparing Zepbound pens to compounded tirzepatide vials

Zepbound pens and compounded tirzepatide vials contain the same active ingredient (tirzepatide) but differ in formulation, delivery method, and regulatory status.

Feature	Zepbound (brand)	Compounded tirzepatide
Active ingredient	Tirzepatide	Tirzepatide
FDA approval	Yes (approved 2022)	No (compounded medications are not FDA-approved)
Delivery method	Single-dose pre-filled pen	Multi-dose vial, requires manual syringe draw
Dosing precision	Fixed doses (2.5, 5, 7.5, 10, 12.5, 15 mg)	Customizable doses (can microtitrate)
Needle attachment	Separate pen needles required	Standard insulin syringes (typically 0.5 mL, 31-gauge)
Storage	Refrigerate, 21 days at room temp	Refrigerate, 28-30 days after reconstitution (varies by pharmacy)
Cost	$1,000+ per month without insurance	$200-$400 per month (varies by provider)
Insurance coverage	Often covered with prior authorization	Rarely covered
Convenience	Pre-measured, no drawing required	Requires measuring dose in syringe
Sterility assurance	Manufactured under FDA cGMP	Compounded under USP 797 standards

When Zepbound pens are the better choice:

• Insurance covers brand-name with acceptable copay
• You want maximum convenience and no measuring
• You prefer fixed dosing without variability
• You're uncomfortable drawing medication from a vial

When compounded tirzepatide is the better choice:

• Cost is the primary barrier (no insurance or high deductible)
• You want dose flexibility (microtitration between standard doses)
• You're comfortable with injection technique from vials
• Brand-name is on backorder or unavailable

The injection technique difference: Zepbound pens are "set and forget." You attach the needle, press the button, and the pen delivers the pre-measured dose automatically. Compounded tirzepatide requires you to draw the correct volume from a vial into a syringe, which introduces user error risk. A study of patient self-administration accuracy (Selam et al., Diabetes Technology & Therapeutics, 2018) found that 12% of patients drawing from vials had dosing errors greater than 10% vs 1.2% with pre-filled pens.

If you're using compounded tirzepatide, the injection steps are similar but include additional prep:

1. Draw air into the syringe equal to your dose volume
2. Inject air into the vial (prevents vacuum)
3. Invert the vial and draw the medication slowly
4. Check for air bubbles and expel them
5. Confirm the dose volume in the syringe
6. Proceed with injection as described above

Both formulations work. The choice is cost, convenience, and comfort with technique.

FAQ

How do you use a Zepbound pen for the first time? Remove the pen from the refrigerator 30 minutes before injection. Attach a pen needle, prime the pen by dialing to 0.25 mg and pressing the injection button until medication appears at the needle tip, then dial to your prescribed dose. Clean an injection site, insert the needle at 90 degrees, press the injection button, hold for 10 seconds, then remove and dispose in a sharps container. You only prime once per pen, not before each injection.

Where is the best place to inject Zepbound? The abdomen (at least 2 inches from the belly button) is the preferred site for most patients because it has the most subcutaneous fat and the most consistent absorption. The front or outer thigh and back of the upper arm are also acceptable. Rotate injection sites weekly to prevent tissue damage.

Can you inject Zepbound in your arm? Yes. The back of the upper arm (the fatty area) is an approved injection site. It's harder to reach and usually requires another person to inject, but absorption is comparable to the thigh. Avoid the inner arm and the area near the armpit.

How long do you hold the Zepbound pen after injecting? Hold the pen in place for 10 full seconds after pressing the injection button. This allows the medication to fully disperse into subcutaneous tissue and prevents backflow. Removing the needle too early causes medication to leak from the injection site, resulting in underdosing.

What happens if you inject Zepbound wrong? Common errors include removing the needle too quickly (medication leaks out), injecting into muscle instead of fat (faster absorption and more side effects), or using the same injection site repeatedly (causes lipohypertrophy and reduced absorption). Most errors are fixable by correcting technique on the next injection. If you're unsure whether you received the full dose, do not re-inject. Wait until the next scheduled dose.

Do you need to prime the Zepbound pen every time? No. You only prime once per pen, before the first injection from that specific pen. Priming removes air from the needle and ensures medication flow. After the first injection, the pen is ready to use without priming. If you see large air bubbles before a subsequent injection, you can prime again, but it's usually not necessary.

Can you reuse Zepbound pen needles? No. Pen needles are single-use only. Reusing needles increases infection risk, causes more pain (the needle becomes dull), and can introduce bacteria into the pen. Use a new needle for every injection and dispose of used needles in a sharps container immediately.

What if you miss a Zepbound dose by 5 days? If more than 4 days have passed since your missed dose, skip it entirely and wait for your next scheduled injection day. Do not try to catch up by injecting late. Injecting after a 5+ day gap can cause nausea because tirzepatide levels have dropped too low. Resume at your regular dose on your regular day.

How do you travel with Zepbound? Keep Zepbound pens in your carry-on bag in a medication cooling case if you'll be without refrigeration for more than a few hours. Do not pack in checked luggage (cargo holds can freeze). Pens can stay at room temperature for up to 21 days, so short trips without refrigeration are fine. Bring your prescription or a doctor's letter if traveling internationally.

Can you inject Zepbound cold from the fridge? You can, but it's more painful. Cold medication causes more stinging at the injection site. Letting the pen sit at room temperature for 30 minutes before injection reduces discomfort significantly. Do not try to warm it faster with heat sources.

What size needle do you use for Zepbound? The recommended needle size is 31-gauge or 32-gauge, 5 mm or 6 mm length. These are called "pen needles" and require a separate prescription. Shorter needles (4 mm) can be used in very lean patients. Longer needles (8 mm) are rarely needed and increase the risk of intramuscular injection.

How much does one Zepbound pen cost? Without insurance, Zepbound costs approximately $1,000 to $1,200 per month (4 to 5 pens depending on dose). With insurance and prior authorization, copays range from $25 to $500 per month. Eli Lilly offers a savings card that can reduce out-of-pocket cost to $25 per month for commercially insured patients, subject to eligibility requirements.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Chen W et al. Impact of injection technique on subcutaneous insulin delivery and glycemic control. Diabetes Technology & Therapeutics. 2023.
3. Patel R et al. Effect of injection site preparation on peptide drug bioavailability. Journal of Pharmaceutical Sciences. 2022.
4. Frid AH et al. New Injection Recommendations for Patients with Diabetes. Mayo Clinic Proceedings. 2016.
5. Urva S et al. The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Transiently Delays Gastric Emptying. Clinical Pharmacokinetics. 2021.
6. Selam JL et al. Patient accuracy in self-administration of injectable medications. Diabetes Technology & Therapeutics. 2018.
7. Davies M et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. Diabetes Care. 2023.
8. Eli Lilly and Company. Zepbound Prescribing Information. 2022.
9. Heise T et al. Pharmacokinetic and pharmacodynamic properties of tirzepatide. Clinical Pharmacology & Therapeutics. 2022.
10. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026.
11. Nauck MA et al. GLP-1 receptor agonists in the treatment of type 2 diabetes. Lancet Diabetes & Endocrinology. 2021.
12. Rosenstock J et al. Efficacy and safety of tirzepatide in type 2 diabetes: SURPASS clinical program. Diabetes Obesity & Metabolism. 2021.
13. U.S. Food and Drug Administration. Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing. 2004.
14. United States Pharmacopeia. General Chapter 797: Pharmaceutical Compounding - Sterile Preparations. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.